SwePub
Tyck till om SwePub Sök här!
Sök i LIBRIS databas

  Extended search

WFRF:(Inamoto Yoshihiro)
 

Search: WFRF:(Inamoto Yoshihiro) > (2016) > Atsuta Yoshiko > Comparing Outcomes ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions.

Kumar, Rajat (author)
Kimura, Fumihiko (author)
Ahn, Kwang Woo (author)
show more...
Hu, Zhen-Huan (author)
Kuwatsuka, Yachiyo (author)
Klein, John P (author)
Pasquini, Marcelo (author)
Miyamura, Koichi (author)
Kato, Koji (author)
Yoshimi, Ayami (author)
Inamoto, Yoshihiro (author)
Ichinohe, Tatsuo (author)
Wood, William Allen (author)
Wirk, Baldeep (author)
Seftel, Matthew (author)
Rowlings, Philip (author)
Marks, David I (author)
Schultz, Kirk R (author)
Gupta, Vikas (author)
Dedeken, Laurence (author)
George, Biju (author)
Cahn, Jean-Yves (author)
Szer, Jeff (author)
Lee, Jong Wook (author)
Ho, Aloysius Y L (author)
Fasth, Anders, 1945 (author)
Gothenburg University,Göteborgs universitet,Institutionen för kliniska vetenskaper, Avdelningen för pediatrik,Institute of Clinical Sciences, Department of Pediatrics
Hahn, Theresa (author)
Khera, Nandita (author)
Dalal, Jignesh (author)
Bonfim, Carmem (author)
Aljurf, Mahmoud (author)
Atsuta, Yoshiko (author)
Saber, Wael (author)
show less...
 (creator_code:org_t)
Elsevier BV, 2016
2016
English.
In: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. - : Elsevier BV. - 1523-6536. ; 22:5, s. 932-940
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Bone marrow (BM) is the preferred graft source for hematopoietic stem cell transplantation (HSCT) in severe aplastic anemia (SAA) compared with mobilized peripheral blood stem cells (PBSCs). We hypothesized that this recommendation may not apply to those regions where patients present later in their disease course, with heavier transfusion load and with higher graft failure rates. Patients with SAA who received HSCT from an HLA-matched sibling donor from 1995 to 2009 and reported to the Center for International Blood and Marrow Transplant Research or the Japan Society for Hematopoietic Cell Transplantation were analyzed. The study population was categorized by gross national income per capita and region/countries into 4 groups. Groups analyzed were high-income countries (HIC), which were further divided into United States-Canada (n = 486) and other HIC (n = 1264); upper middle income (UMIC) (n = 482); and combined lower-middle, low-income countries (LM-LIC) (n = 142). In multivariate analysis, overall survival (OS) was highest with BM as graft source in HIC compared with PBSCs in all countries or BM in UMIC or LM-LIC (P < .001). There was no significant difference in OS between BM and PBSCs in UMIC (P = .32) or LM-LIC (P = .23). In LM-LIC the 28-day neutrophil engraftment was higher with PBSCs compared with BM (97% versus 77%, P < .001). Chronic graft-versus-host disease was significantly higher with PBSCs in all groups. Whereas BM should definitely be the preferred graft source for HLA-matched sibling HSCT in SAA, PBSCs may be an acceptable alternative in countries with limited resources when treating patients at high risk of graft failure and infective complications.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Pediatrik (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Pediatrics (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view